| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cogent Biosciences, Inc. (COGT) has 13 insiders with recent SEC Form 4 filings, including 5 buys and 29 sells. COGT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 12.50M | $434.99M | - | |
| Other | 216.7K | $7.54M | - | |
| CEO | 185.0K | $6.44M | - | |
| Other | 140.0K | $4.87M | - | |
| Other | 133.9K | $4.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | Venrock Healthcare Capital Partners Iii, L.P.54 | 10% Owner | Buy | 451,000 | $2.52 | $1,137,120.00 | +3.7% | |
| May 12, 2020 | Campana Dario | 10% Owner | Sell | 2,000,000 | $0.39 | $788,383.23 | -2.1% | |
| Mar 25, 2019 | Ettenberg Seth | Chief Scientific Officer | Sale+OE | 11,485 | $4.12 | $47,334.28 | -100% | |
| Feb 25, 2019 | Ettenberg Seth | Chief Scientific Officer | Sale+OE | 11,485 | $4.25 | $48,852.60 | -100% | |
| Dec 26, 2018 | Ettenberg Seth | Chief Scientific Officer | Sale+OE | 11,485 | $4.05 | $46,486.69 | -100% | |
| Nov 26, 2018 | Ettenberg Seth | Chief Scientific Officer | Sale+OE | 11,485 | $7.00 | $80,444.39 | -100% | |
| Oct 25, 2018 | Ettenberg Seth | Chief Scientific Officer | Sale+OE | 11,485 | $8.46 | $97,201.00 | -100% | |
| Sep 25, 2018 | Ettenberg Seth | Chief Scientific Officer | Sale+OE | 11,485 | $12.47 | $143,181.20 | -100% | |
| Apr 3, 2018 | Booth Bruce70 | Director | Buy | 94,052 | $12.00 | $1,128,624.00 | +2.9% | |
| Apr 3, 2018 | Fmr LLC72 | See Remark 1 | Buy | 94,052 | $12.00 | $1,128,624.00 | +26.3% |